Read the latest blogs from across our work within the secondary breast cancer community. From blogs on fundraising, research findings, information sharing, corporate achievements, community support and stories, celebrate with us as we work together to Make 2nds Count.
![ed680ad9 0d83 48a3 90d9 037a6fa5baab](/assets/Uploads/ed680ad9-0d83-48a3-90d9-037a6fa5baab__FocusFillWyIwLjAwIiwiMC4wMCIsNTAwLDMwMF0.jpg)
Lorna's Story
We're sharing stories from some of our wonderful members of the community who have a diagnosis of Triple Negative. Lorna shares her story.
![image0 11](/assets/Uploads/image0-11__FocusFillWyIwLjAxIiwiMC4zOSIsNTAwLDMwMF0.jpeg)
Sarah's story
We're sharing stories from some of our wonderful members of the community who have a diagnosis of Triple Negative. Sarah shares her story.
![7d7e935a cc3a 4831 a120 370f2ef1c994](/assets/Uploads/7d7e935a-cc3a-4831-a120-370f2ef1c994__FocusFillWyItMC4wMyIsIi0wLjQxIiw1MDAsMzAwXQ.jpg)
Helen's story
We're sharing stories from some of our wonderful members of the community who have a diagnosis of Triple Negative. Helen shares her story.
![IMG 3986](/assets/Uploads/IMG_3986__FocusFillWyIwLjAwIiwiMC4wMCIsNTAwLDMwMF0.jpeg)
Jess's story
We're sharing stories from some of our wonderful members of the community who have a diagnosis of Triple Negative. Jess shares her story.
![Main image](/assets/Uploads/Main-image__FocusFillWyIwLjAwIiwiMC4wMCIsNTAwLDMwMF0.jpg)
Keytruda for Secondary Breast Cancer: Science and Stories
Pembrolizumab, also known as Keytruda®, is a drug used to treat a variety of cancers1. In breast cancer, Keytruda is currently used to treat both early and secondary triple negative breast cancer (TNBC).
![image0 10](/assets/Uploads/image0-10__FocusFillWyItMC4xNSIsIi0wLjYxIiw1MDAsMzAwXQ.jpeg)
Lisa's story
We're sharing stories from some of our wonderful members of the community who have a diagnosis of Triple Negative. Lisa shares her story.
![IMG 6040](/assets/Uploads/IMG_6040__FocusFillWyItMC4wNCIsIi0wLjUxIiw1MDAsMzAwXQ.jpeg)
Mary's story for Triple Negative Breast Cancer Day
For #TripleNegativeBreastCancerDay (Sun 3 March, 2024) we are shining a light on some of our wonderful members of the community who have a diagnosis of Triple Negative. Mary shares her story.
![IMG 20230719 WA0054](/assets/Uploads/IMG-20230719-WA0054__FocusFillWyIwLjAwIiwiMC4wMCIsNTAwLDMwMF0.jpg)
Kathryn's story for Triple Negative Breast Cancer Day
For #TripleNegativeBreastCancerDay (Sun 3 March, 2024) we are shining a light on some of our wonderful members of the community who have a diagnosis of Triple Negative. Kathryn shares her story.
![Abseil](/assets/Uploads/Abseil__FocusFillWyIwLjAwIiwiMC4wMCIsNTAwLDMwMF0.jpg)
Lianne gets ready for the Falkirk Wheel Abseil Challenge
Next month sees the launch of one of our new fundraising challenges: Abseiling the Falkirk Wheel! Lianne from the Make 2nds Count Fundraising Team will be taking part in this epic challenge to raise money to help support secondary breast cancer patients.
Marette Edwards Story and fundraising for M2C
We recently caught up with one of our ambassadors Marette, who's husband has signed up to take part in the London Marathon in April. We wanted to know a bit about Marette and why her husband has choose to fundraise for Make 2nds Count.
![Jo Anne Hodkinson](/assets/Uploads/Jo-Anne-Hodkinson__FocusFillWyIwLjAwIiwiMC4wMCIsNTAwLDMwMF0.jpeg)
SBC & Me
SBC & ME Date of Diagnosis: 13/04/2021 Current Treatment Line: Palbociclib, denosumab, zoladex, apixaban, letrozole How Does SBC Affect Your Life: The cancer is in my bones and I had a proximal femoral endoprosthetic replacement (replacement of hip socket and femur) walking is difficult and the distance is limited. I still work full time as it provides my normality and a distraction from the cancer world of hospital appointments and scans.
![AI Cover Image](/assets/Uploads/AI-Cover-Image__FocusFillWyIwLjAwIiwiMC4wMCIsNTAwLDMwMF0.jpg)
Aromatase Inhibitors for Secondary Breast Cancer: Science and Stories
Aromatase inhibitors are a class of drugs that can be used to treat hormone receptor-positive (HR+) subtypes of breast cancer1. Aromatase inhibitors can be used in the treatment of early HR+ breast cancer, but here we will focus on aromatase inhibitors in treating secondary (metastatic, advanced) breast cancer.
![Fundraising collage](/assets/Uploads/Fundraising-collage__FocusFillWyIwLjAwIiwiMC4wMCIsNTAwLDMwMF0.jpg)
2023 Fundraising round up
Make 2nds Count have had an incredible year of fundraising in 2023. As we look back at some of the amazing fundraising events we would like to thank all our supporters for all events big and small and for making it the year that it was.
![pink glassware](/assets/research/pink-glassware__FocusFillWyIwLjAwIiwiMC4wMCIsNTAwLDMwMF0.jpg)
2023 Research Round Up
What a busy year it has been in Research! Since welcoming our new Research Manager, Dr Sarah Thomas, we have completed our first research grant awarded by the charity, announced our largest ever grant and launched our first open call for research proposals to kick off in 2024.
![Retreat Newsletter May graphic](/assets/Uploads/Retreat-Newsletter-May-graphic__FocusFillWyIwLjAwIiwiMC4wMCIsNTAwLDMwMF0.png)
2023 Support Roundup
We've had an incredibly exciting and busy year for our support services as they continue to grow and meet the needs of the community. In 2023 we have delivered: 106 attendees at our 2nds Together wellbeing retreats 12 Tea & A Chat groups around the UK 1300 '2nds Together' private group members 432 littlelift boxes sent 334 Little Book of Admin sent 348 Birdsong yoga attendees Our first event of 2023 was the online 'Wellbeing Week' in February with the focus on Menopause and its impact on those living with secondary breast cancer.